Markets & Regulations

GettyImages/Harvepino

First Herceptin biosimilar launched in UK

By Staff Reporter

Merck & Co. will take on Roche as Ontruzant becomes the first biosimilar of cancer drug Herceptin (trastuzumab) to be launched in Europe.